Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person SEPT9 sequence alternations causing hereditary neuralgic amyotrophy are associated with altered interactions with SEPT4/SEPT11 and resistance to Rho/Rhotekin-signaling

Class:IdLiteratureReference:5672992
_displayNameSEPT9 sequence alternations causing hereditary neuralgic amyotrophy are associated with altered interactions with SEPT4/SEPT11 and resistance to Rho/Rhotekin-signaling
_timestamp2015-02-06 16:00:58
author[Person:5666204] Sudo, Kaori
[Person:5666203] Ito, Hidenori
[Person:5666207] Iwamoto, Ikuko
[Person:5666201] Morishita, Rika
[Person:5666208] Asano, Tomiko
[Person:5666205] Nagata, Koh-ichi
created[InstanceEdit:5672989] Orlic-Milacic, Marija, 2015-02-06
journalHum. Mutat.
pages1005-13
pubMedIdentifier17546647
titleSEPT9 sequence alternations causing hereditary neuralgic amyotrophy are associated with altered interactions with SEPT4/SEPT11 and resistance to Rho/Rhotekin-signaling
volume28
year2007
(literatureReference)[Pathway:5666185] RHO GTPases Activate Rhotekin and Rhophilins [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by SEPT9 sequence alternations causing hereditary neuralgic amyotrophy are associated with altered interactions with SEPT4/SEPT11 and resistance to Rho/Rhotekin-signaling (5672992)